| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
2880 Stock Overview
Shenzhen Weiguang Biological Products Co., Ltd.
Shenzhen Weiguang Biological Products Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥25.38 |
| 52 Week High | CN¥37.00 |
| 52 Week Low | CN¥21.50 |
| Beta | 0.10 |
| 1 Month Change | -2.01% |
| 3 Month Change | 2.09% |
| 1 Year Change | -26.41% |
| 3 Year Change | 20.91% |
| 5 Year Change | -7.40% |
| Change since IPO | 47.40% |
Recent News & Updates
Shareholder Returns
| 2880 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 1.0% | 0.4% | -0.5% |
| 1Y | -26.4% | -33.3% | -10.4% |
Return vs Industry: 002880 exceeded the CN Biotechs industry which returned -33.3% over the past year.
Return vs Market: 002880 underperformed the CN Market which returned -10.4% over the past year.
Price Volatility
| 2880 volatility | |
|---|---|
| 2880 Average Weekly Movement | 3.4% |
| Biotechs Industry Average Movement | 5.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in CN Market | 9.2% |
| 10% least volatile stocks in CN Market | 3.9% |
Stable Share Price: 002880 is less volatile than 75% of CN stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: 002880's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 759 | Zhan Zhang | https://www.szwg.com |
Shenzhen Weiguang Biological Products Co., Ltd. primarily engages in the research, development, production, and sale of blood products in China. The company offers human albumin, intravenous immunoglobulin (pH4), freeze-dried intravenous human immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, rabies patient immunoglobulin, tetanus human immunoglobulin, histamine human immunoglobulin, and human fibrinogen, as well as a total of 9 varieties and 21 specifications.
Shenzhen Weiguang Biological Products Co., Ltd. Fundamentals Summary
| 2880 fundamental statistics | |
|---|---|
| Market Cap | CN¥5.76b |
| Earnings (TTM) | CN¥203.78m |
| Revenue (TTM) | CN¥906.57m |
28.2x
P/E Ratio6.3x
P/S RatioIs 2880 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2880 income statement (TTM) | |
|---|---|
| Revenue | CN¥906.57m |
| Cost of Revenue | CN¥533.09m |
| Gross Profit | CN¥373.48m |
| Other Expenses | CN¥169.70m |
| Earnings | CN¥203.78m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.90 |
| Gross Margin | 41.20% |
| Net Profit Margin | 22.48% |
| Debt/Equity Ratio | 10.2% |
How did 2880 perform over the long term?
See historical performance and comparison